Trzy Lipy 3/1.38
Gdansk 80-172
Poland
48 58 739 6150
https://www.blirt.eu
Sector(s):
Industry:
Full-time employees: 70
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Thierry Bernard | Chief Executive Officer | N/A | N/A | N/A |
Mr. Krzysztof Kur Ph.D. | Member of the Managing Board & R&D | N/A | N/A | N/A |
Mr. Tomasz Wrzesinski | Member of the Managing Board | N/A | N/A | N/A |
Katarzyna Spirin-Polak | Member of the Managing Board | N/A | N/A | N/A |
Roland Sackers | Member of the Managing Board | N/A | N/A | N/A |
Ms. Aleksandra Kukiello | Chief Business Support Officer | N/A | N/A | N/A |
Mr. Piotr Wierzbicki | Secretary & Member of the Supervisory Board | N/A | N/A | N/A |
BLIRT S.A. engages in the manufacture and sale of recombinant enzymes for the life science industry. It offers proteins and enzymes, such as proteinases, RNase inhibitors, polymerases, nucleases, ligases, and other proteins; and molecular biology reagents, including DNA and RNA extraction, PCR and real-time PCR, reverse transcriptions, and RNA related products. BLIRT S.A. was founded in 1994 and is headquartered in Gdansk, Poland. BLIRT S.A. operates as a subsidiary of Qiagen N.V.
BLIRT S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.